Andy has worked for over 30 years in the pharmaceutical industry on a wide
range of biological products including botulinum toxin, microbial enzymes, vaccines, natural products and numerous recombinant
proteins, all in the laboratory, development and also in production and quality.
As the toxin scientific expert, Andy worked on botulinum toxin for 23 years for Porton, Speywood and finally
Ipsen. His activities and responsibilities provided scientific and product support and technical expertise
on botulinum toxin structure, function, physiology, assay technologies, quality, regulatory and production areas. He
has liaised and worked with many regulatory authorities around the world, including the US FDA, European authorities
and the Japanese MHW. He was also responsible for external collaborations, technical support
and liaisons with commercial areas.
For the last several years, Andy has focused on translating the science and technology
of botulinum toxin to enable clinicians, dermatologists, plastic surgeons, rehabilitation specialists and medical students
to have a clear understanding of the toxin products available, how they work and how they can be used. His
speciality is translating the current, state-of-the-art science into practical knowledge and subsequent benefits for the clinical
users and he has been recognised internationally for this work.
Andy founded Toxin Science Limited to continue his work on translating the science
and technology of botulinum toxin into real, practical meaning for clinicians around the world.
Currently member of number of professional bodies:
Parenteral Drug Association
Society of General Microbiology
Society of Chemical Industry
Member of British Pharmacopoeia Panel of Experts BIO: Biological
and Biotechnological Products
Joint inventor on number
of patent applications relating to botulinum toxins